I have an SDHC mutation. Does that factor into risk at all?


SDHC mutations themselves do not lead to an increased risk of acquiring COVID19 or experiencing serious complications. If you are SDHC mutation carrier, it is reasonable to delay biochemical screening if you are up-to-date (performed with the last 18 months). If you have a SDHC mutation and prior disease for which you receive surveillance scans, it is reasonable to delays these scans for a few months. In both of these cases, the risk of COVID19 outweighs the risks of delaying screening or surveillance. If you have an SDHC mutation and are undergoing treatment for cancer, this could increase your risk if these treatments suppress your immune system. [With thanks to Dr. Justin Annes, Stanford Endocrine Genetics].

Posted 11 months agoby globeseek